(Q40296262)

English

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed

scientific article published on September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

7

object named as

Weinehall L

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Norberg M

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Eriksson JW

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lindahl B

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Andersson C

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Rolandsson O

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Stenlund H

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

260

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

263-271

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Targeting people with pre-diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

The nested case-control study in cardiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64 years of age in northern Sweden

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Hemoglobin A1c can be analyzed in blood kept frozen at -80 degrees C and is not commonly affected by hemolysis in the general population.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Self-rated ill-health strengthens the effect of biomedical risk factors in predicting stroke, especially for men -- an incident case referent study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Impaired glucose tolerance and fasting hyperglycaemia have different characteristics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01689.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2006.01689.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40296262&oldid=1894171998"